STK11 and squamous cell lung carcinoma: The prevalence of LKB1 alterations in LUACs is 8–21% [27,28,29,30,31], whereas in Lung Squamous Cell Carcinoma (LSCCs), LKB1 alterations are detected in 1.5–5% of patients [26,28].